Vertex makes biggest acquisition to date for IgA nephropathy treatment
USA—Vertex Pharmaceuticals has announced its plan to acquire biotechnology company Alpine Immune...
Read More
Tag: Vertex Pharmaceuticals
Vertex advances Inaxaplin to Phase 3 trial for treatment of APOL1-Mediated Kidney Disease
USA — Vertex Pharmaceuticals, a leading American biopharmaceutical company headquartered in...
Read More
US FDA greenlights historic CRISPR-based gene therapies for Sickle Cell Disease
USA – The US Food and Drug Administration (FDA) has granted approval for the groundbreaking...
Read More
UK grants conditional approval for Vertex and CRISPR Therapeutics’ Casgevy, the first CRISPR-based gene-editing therapy
UNITED KINGDOM – The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has...
Read More
CRISPR-based sickle cell treatment inches closer to FDA approval
USA — A cutting-edge sickle cell disease treatment utilizing CRISPR technology has achieved a...
Read More
Game-changing gene therapies inch closer to FDA approval, but pricing looms large
USA —A transformative shift in medical treatment is on the horizon, as the U.S. Food and Drug...
Read More
LATEST DIGITAL MAGAZINE
